These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 10811694)

  • 1. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
    Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
    Zakzanis KK; Campbell Z; Jovanovski D
    Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
    Hoshi R; Mullins K; Boundy C; Brignell C; Piccini P; Curran HV
    Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive performance amongst recreational users of "ecstasy".
    Rodgers J
    Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.
    de Sola S; Tarancón T; Peña-Casanova J; Espadaler JM; Langohr K; Poudevida S; Farré M; Verdejo-García A; de la Torre R
    Psychopharmacology (Berl); 2008 Oct; 200(3):425-37. PubMed ID: 18581098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
    Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
    Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
    Burgess AP; Venables L; Jones H; Edwards R; Parrott AC
    Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.